Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Darko Curman"'
Autor:
Aaron A. Goodarzi, Paul Clarke, Darko Curman, Bruno Cinel, Bin-Bing S. Zhou, David E. Williams, James R. A. Hutchins, Wesley D. Block, Michel Roberge, Raymond J. Andersen, Susan P. Lees-Miller, Natalie T. Rundle
Publikováno v:
ResearcherID
Cells can respond to DNA damage by activating checkpoints that delay cell cycle progression and allow time for DNA repair. Chemical inhibitors of the G(2) phase DNA damage checkpoint may be used as tools to understand better how the checkpoint is reg
Autor:
Aly Karsan, Darko Curman, Mohamed Elemary, Elaine Law, Sean D. Young, Haji Chalchal, Mirjana Zarkovic
Publikováno v:
Journal of Medical Genetics. 52:A13.1-A13
Chronic Myeloid Leukaemia (CML) is a hematopoietic disorder characterised by an increased proliferation of predominantly the myeloid lineage in the bone marrow and consequently the accumulation of these cells in the blood. It is caused by a transloca
Autor:
Hiromi Shimizu, Darko Curman, Kevin She, Sophie L. Corthals, Kristy Garbutt, Gregor S. D. Reid, Kristin Wynne
Publikováno v:
British journal of haematology. 132(4)
Acute lymphoblastic leukaemia (ALL) is the most common paediatric malignancy and, although current therapy is widely effective, relapse remains a significant clinical problem for which new treatment strategies are required. The ligation of Toll-like
Autor:
Gregor S. D. Reid, Kristy Garbutt, Sophie L. Corthals, Kevin She, Darko Curman, Kristin Wynne
Publikováno v:
Journal of Pediatric Hematology/Oncology. 27:468-469
Autor:
Darko Curman, Kristy Garbutt, Joan Mathers, Kevin She, Gregor S. D. Reid, Heather Wildgrove, Kristin Wynne
Publikováno v:
Blood. 104:1887-1887
Pediatric pre-B acute lymphoblastic leukemia is the most common childhood cancer. Although current therapies achieve a high rate of remission, relapse of pre-B ALL remains a significant clinical challenge and new forms of therapy are needed. The graf